Loading...
Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor
NK cells have emerged as promising candidates for cancer immunotherapy, especially due to their ability to fight circulating tumor cells thereby preventing metastases formation. Hence several studies have been performed to generate and expand highly cytotoxic NK cells ex vivo, e.g., by using specifi...
Na minha lista:
| Udgivet i: | Front Bioeng Biotechnol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700243/ https://ncbi.nlm.nih.gov/pubmed/31457007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2019.00194 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|